Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH3 DNAH2 DNAH1 DNAH17 DYNC1H1 DNAH11	2.92e-09	18	151	6	GO:0008569
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH3 DNAH2 DNAH1 DNAH17 DYNC1H1 DNAH11	5.56e-08	28	151	6	GO:0051959
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH3 DNAH2 DNAH1 DNAH17 DYNC1H1 DNAH11	3.24e-07	37	151	6	GO:0045505
GeneOntologyMolecularFunction	microtubule motor activity	DNAH3 DNAH2 DNAH1 DNAH17 DYNC1H1 DYNC1I2 DNAH11	9.90e-07	70	151	7	GO:0003777
GeneOntologyMolecularFunction	antigen binding	IGKV1-39 HLA-B TGFB1 IGLC7 IGLC1 IGLC2 IGLC3 IGLC6 IGKV1D-39	1.46e-05	190	151	9	GO:0003823
GeneOntologyMolecularFunction	cytoskeletal motor activity	DNAH3 DNAH2 DNAH1 DNAH17 DYNC1H1 DYNC1I2 DNAH11	3.22e-05	118	151	7	GO:0003774
GeneOntologyMolecularFunction	NADH oxidase H202-forming activity	DUOX2 DUOX1	5.68e-05	2	151	2	GO:0106293
GeneOntologyMolecularFunction	sulfur compound transmembrane transporter activity	ABCC1 SLC36A1 SLC19A3 ABCC11 SLC6A6	9.79e-05	61	151	5	GO:1901682
GeneOntologyMolecularFunction	neurexin family protein binding	NLGN4Y NLGN3 NLGN4X	2.21e-04	16	151	3	GO:0042043
GeneOntologyMolecularFunction	taurine transmembrane transporter activity	SLC36A1 SLC6A6	5.60e-04	5	151	2	GO:0005368
GeneOntologyMolecularFunction	NADPH oxidase H202-forming activity	DUOX2 DUOX1	5.60e-04	5	151	2	GO:0106294
GeneOntologyMolecularFunction	hydrolase activity, acting on glycosyl bonds	MAN2B1 NAGLU GBA2 CEMIP IL1RAPL1 IL1RL1	8.01e-04	144	151	6	GO:0016798
GeneOntologyMolecularFunction	ATP-dependent activity	ABCC1 DNAH3 DNAH2 ABCC11 DHX57 MSH2 DNAH1 ACSL1 NAE1 DNAH17 DYNC1H1 DYNC1I2 DNAH11	8.03e-04	614	151	13	GO:0140657
GeneOntologyMolecularFunction	phosphatidylcholine transfer activity	PITPNA PITPNB	8.35e-04	6	151	2	GO:0120019
GeneOntologyMolecularFunction	DNA insertion or deletion binding	XPC MSH2	8.35e-04	6	151	2	GO:0032135
GeneOntologyBiologicalProcess	neuron cell-cell adhesion	NLGN4Y NCAM2 NLGN3 NLGN4X ASTN2	9.48e-08	16	156	5	GO:0007158
GeneOntologyBiologicalProcess	immunoglobulin production	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 MSH2 TGFB1 IGLV3-10 IGKV3D-11 PRKDC IGKV1D-43 IGKV1D-39 IGKV1D-8	3.14e-07	241	156	12	GO:0002377
GeneOntologyBiologicalProcess	adaptive immune response	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 WAS HLA-B BTNL8 MSH2 ITK TGFB1 IGLV3-10 JAK1 IGLC7 IGKV3D-11 IGLC1 IGLC2 IGLC3 IL1RL1 IGLC6 IGKV1D-43 IGKV1D-39 IGKV1D-8	3.63e-07	838	156	22	GO:0002250
GeneOntologyBiologicalProcess	presynaptic membrane assembly	NLGN4Y IL1RAPL1 NLGN3 NLGN4X	6.38e-07	10	156	4	GO:0097105
GeneOntologyBiologicalProcess	presynaptic membrane organization	NLGN4Y IL1RAPL1 NLGN3 NLGN4X	2.13e-06	13	156	4	GO:0097090
GeneOntologyBiologicalProcess	production of molecular mediator of immune response	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 MSH2 TGFB1 IGLV3-10 IGKV3D-11 PRKDC IGKV1D-43 IGKV1D-39 IGKV1D-8	5.89e-05	403	156	12	GO:0002440
GeneOntologyBiologicalProcess	postsynaptic membrane assembly	NLGN4Y NLGN3 NLGN4X	6.70e-05	11	156	3	GO:0097104
GeneOntologyCellularComponent	immunoglobulin complex	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 IGLV3-10 IGLC7 IGKV3D-11 IGLC1 IGLC2 IGLC3 IGLC6 IGKV1D-43 IGKV1D-39 IGKV1D-8	3.25e-11	166	158	14	GO:0019814
GeneOntologyCellularComponent	IgG immunoglobulin complex	IGLC7 IGLC1 IGLC2 IGLC3 IGLC6	4.39e-08	14	158	5	GO:0071735
GeneOntologyCellularComponent	IgD immunoglobulin complex	IGLC7 IGLC1 IGLC3 IGLC6	4.66e-08	6	158	4	GO:0071738
GeneOntologyCellularComponent	IgE immunoglobulin complex	IGLC7 IGLC1 IGLC3 IGLC6	4.66e-08	6	158	4	GO:0071742
GeneOntologyCellularComponent	IgA immunoglobulin complex	IGLC7 IGKV3D-11 IGLC1 IGLC3 IGLC6	6.54e-08	15	158	5	GO:0071745
GeneOntologyCellularComponent	IgM immunoglobulin complex	IGLC7 IGKV3D-11 IGLC1 IGLC3 IGLC6	6.54e-08	15	158	5	GO:0071753
GeneOntologyCellularComponent	dynein complex	DNAH3 DNAH2 DNAH1 DNAH17 DYNC1H1 DYNC1I2 DNAH11	1.62e-07	54	158	7	GO:0030286
GeneOntologyCellularComponent	axonemal dynein complex	DNAH3 DNAH2 DNAH1 DNAH17 DYNC1I2	1.09e-06	25	158	5	GO:0005858
GeneOntologyCellularComponent	symmetric, GABA-ergic, inhibitory synapse	NLGN4Y NLGN3 NLGN4X	1.69e-06	4	158	3	GO:0098983
GeneOntologyCellularComponent	inner dynein arm	DNAH3 DNAH2 DNAH1	4.89e-05	10	158	3	GO:0036156
GeneOntologyCellularComponent	cell surface	EPOR VLDLR HLA-B BTNL8 NLGN4Y RER1 DUOX2 ACVR2A PTGFRN TGFB1 IL1RAPL1 NLGN3 DUOX1 NLGN4X LMO7 CLPTM1 CD48 KCNQ3 CCR3 ROS1 IL1RL1	9.88e-05	1111	158	21	GO:0009986
GeneOntologyCellularComponent	symmetric synapse	NLGN4Y NLGN3 NLGN4X	1.15e-04	13	158	3	GO:0032280
GeneOntologyCellularComponent	microtubule associated complex	DNAH3 DNAH2 DNAH1 DNAH17 DYNC1H1 DYNC1I2 DNAH11	2.27e-04	161	158	7	GO:0005875
GeneOntologyCellularComponent	cilium	DNAH3 MCHR1 EFCAB6 SPEF2 RTTN DNAH2 BBS4 PTCH1 DNAH1 CC2D2B ALMS1 DNAH17 DLEC1 CEP126 CATSPERG DYNC1I2 DNAH11	4.65e-04	898	158	17	GO:0005929
GeneOntologyCellularComponent	asymmetric, glutamatergic, excitatory synapse	NLGN4Y NLGN3 NLGN4X	7.63e-04	24	158	3	GO:0098985
GeneOntologyCellularComponent	blood microparticle	IGKV1-39 GSN TGFB1 IGLC1 IGLC2 IGLC3	8.01e-04	144	158	6	GO:0072562
GeneOntologyCellularComponent	axoneme	DNAH3 EFCAB6 DNAH2 DNAH1 DNAH17 DYNC1I2 DNAH11	1.02e-03	207	158	7	GO:0005930
GeneOntologyCellularComponent	ciliary plasm	DNAH3 EFCAB6 DNAH2 DNAH1 DNAH17 DYNC1I2 DNAH11	1.05e-03	208	158	7	GO:0097014
GeneOntologyCellularComponent	GABA-ergic synapse	NLGN4Y SLC6A6 NLGN3 NLGN4X PTPRO CLPTM1	1.57e-03	164	158	6	GO:0098982
GeneOntologyCellularComponent	inhibitory synapse	NLGN4Y NLGN3 NLGN4X	1.63e-03	31	158	3	GO:0060077
GeneOntologyCellularComponent	apical part of cell	ABCC1 VLDLR SLC36A1 SPP1 ABCC11 DUOX2 PTCH1 SLC6A6 DUOX1 LMO7 PTPRO PTPRQ	1.85e-03	592	158	12	GO:0045177
GeneOntologyCellularComponent	9+2 motile cilium	DNAH3 SPEF2 DNAH2 DNAH1 DNAH17 CATSPERG DNAH11	2.26e-03	238	158	7	GO:0097729
GeneOntologyCellularComponent	plasma membrane bounded cell projection cytoplasm	DNAH3 EFCAB6 DNAH2 DNAH1 DNAH17 DYNC1H1 DYNC1I2 DNAH11	2.89e-03	317	158	8	GO:0032838
Domain	Dynein_heavy_chain_D4_dom	DNAH3 DNAH2 DNAH1 DYNC1H1 DNAH11	4.33e-08	14	141	5	IPR024317
Domain	Dynein_HC_stalk	DNAH3 DNAH2 DNAH1 DYNC1H1 DNAH11	4.33e-08	14	141	5	IPR024743
Domain	Dynein_heavy_dom-2	DNAH3 DNAH2 DNAH1 DYNC1H1 DNAH11	4.33e-08	14	141	5	IPR013602
Domain	DHC_N2	DNAH3 DNAH2 DNAH1 DYNC1H1 DNAH11	4.33e-08	14	141	5	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH3 DNAH2 DNAH1 DYNC1H1 DNAH11	4.33e-08	14	141	5	IPR011704
Domain	MT	DNAH3 DNAH2 DNAH1 DYNC1H1 DNAH11	4.33e-08	14	141	5	PF12777
Domain	AAA_8	DNAH3 DNAH2 DNAH1 DYNC1H1 DNAH11	4.33e-08	14	141	5	PF12780
Domain	AAA_5	DNAH3 DNAH2 DNAH1 DYNC1H1 DNAH11	4.33e-08	14	141	5	PF07728
Domain	DHC_fam	DNAH3 DNAH2 DNAH1 DYNC1H1 DNAH11	6.45e-08	15	141	5	IPR026983
Domain	Dynein_heavy	DNAH3 DNAH2 DNAH1 DYNC1H1 DNAH11	6.45e-08	15	141	5	PF03028
Domain	Dynein_heavy_dom	DNAH3 DNAH2 DNAH1 DYNC1H1 DNAH11	6.45e-08	15	141	5	IPR004273
Domain	Carboxylesterase_B_CS	CES5A NLGN4Y NLGN3 NLGN4X	2.11e-06	13	141	4	IPR019819
Domain	CARBOXYLESTERASE_B_2	CES5A NLGN4Y NLGN3 NLGN4X	2.94e-06	14	141	4	PS00941
Domain	COesterase	CES5A NLGN4Y NLGN3 NLGN4X	2.94e-06	14	141	4	PF00135
Domain	CarbesteraseB	CES5A NLGN4Y NLGN3 NLGN4X	2.94e-06	14	141	4	IPR002018
Domain	Nlgn	NLGN4Y NLGN3 NLGN4X	4.17e-06	5	141	3	IPR000460
Domain	DHC_N1	DNAH2 DYNC1H1 DNAH11	2.29e-05	8	141	3	PF08385
Domain	Dynein_heavy_dom-1	DNAH2 DYNC1H1 DNAH11	2.29e-05	8	141	3	IPR013594
Domain	DUOX1	DUOX2 DUOX1	5.66e-05	2	141	2	IPR029595
Domain	NLGN4	NLGN4Y NLGN4X	5.66e-05	2	141	2	IPR030025
Domain	Ig-like_fold	EPOR HLA-B BTNL8 NCAM2 PKHD1L1 PTGFRN IL1RAPL1 TGM4 FNDC7 PTPRO CD48 ASTN2 ROS1 IGLC3 IL1RL1 SDK1	8.72e-05	706	141	16	IPR013783
Domain	-	EPOR HLA-B BTNL8 NCAM2 PKHD1L1 PTGFRN IL1RAPL1 TGM4 FNDC7 PTPRO CD48 ASTN2 ROS1 IL1RL1 SDK1	1.49e-04	663	141	15	2.60.40.10
Domain	HNF-1_N	HMBOX1 HNF1B	1.69e-04	3	141	2	PF04814
Domain	HNF-1_N	HMBOX1 HNF1B	1.69e-04	3	141	2	IPR006899
Domain	-	CES5A NLGN4Y ABHD3 NLGN3 NLGN4X ABHD16A	2.87e-04	119	141	6	3.40.50.1820
Domain	AB_hydrolase	CES5A NLGN4Y ABHD3 NLGN3 NLGN4X ABHD16A	2.87e-04	119	141	6	IPR029058
Domain	G8_domain	PKHD1L1 CEMIP	3.36e-04	4	141	2	IPR019316
Domain	G8	PKHD1L1 CEMIP	3.36e-04	4	141	2	PS51484
Domain	G8	PKHD1L1 CEMIP	3.36e-04	4	141	2	SM01225
Domain	G8	PKHD1L1 CEMIP	3.36e-04	4	141	2	PF10162
Domain	FN3	EPOR NCAM2 FNDC7 PTPRO ASTN2 ROS1 SDK1	5.17e-04	185	141	7	SM00060
Domain	IP_trans	PITPNA PITPNB	5.58e-04	5	141	2	PF02121
Domain	AAA	ABCC1 DNAH3 DNAH2 ABCC11 DYNC1H1 DNAH11	7.90e-04	144	141	6	SM00382
Domain	AAA+_ATPase	ABCC1 DNAH3 DNAH2 ABCC11 DYNC1H1 DNAH11	7.90e-04	144	141	6	IPR003593
Domain	FN3	EPOR NCAM2 FNDC7 PTPRO ASTN2 ROS1 SDK1	7.96e-04	199	141	7	PS50853
Domain	PI_transfer	PITPNA PITPNB	8.32e-04	6	141	2	IPR001666
Domain	FN3_dom	EPOR NCAM2 FNDC7 PTPRO ASTN2 ROS1 SDK1	1.06e-03	209	141	7	IPR003961
Domain	-	KLHL2 IVNS1ABP KLHL5	1.08e-03	27	141	3	2.130.10.80
Domain	Glyco_hydro/deAcase_b/a-brl	MAN2B1 ST6GAL2	1.16e-03	7	141	2	IPR011330
Domain	NAD_binding_6	DUOX2 DUOX1	1.16e-03	7	141	2	PF08030
Domain	FAD_binding_8	DUOX2 DUOX1	1.16e-03	7	141	2	PF08022
Domain	FAD-bd_8	DUOX2 DUOX1	1.16e-03	7	141	2	IPR013112
Domain	Fe_red_NAD-bd_6	DUOX2 DUOX1	1.16e-03	7	141	2	IPR013121
Domain	fn3	EPOR NCAM2 FNDC7 PTPRO ROS1 SDK1	1.45e-03	162	141	6	PF00041
Domain	Pectin_lyase_fold/virulence	PKHD1L1 CEMIP	1.54e-03	8	141	2	IPR011050
Domain	Gal_Oxidase_b-propeller	KLHL2 IVNS1ABP KLHL5	2.12e-03	34	141	3	IPR015916
Domain	An_peroxidase	DUOX2 DUOX1	2.45e-03	10	141	2	PF03098
Domain	Haem_peroxidase_animal	DUOX2 DUOX1	2.45e-03	10	141	2	IPR019791
Domain	Haem_peroxidase	DUOX2 DUOX1	2.45e-03	10	141	2	IPR010255
Domain	PEROXIDASE_3	DUOX2 DUOX1	2.45e-03	10	141	2	PS50292
Domain	-	DUOX2 DUOX1	2.45e-03	10	141	2	1.10.640.10
Domain	IL-1_rcpt_fam	IL1RAPL1 IL1RL1	2.98e-03	11	141	2	IPR015621
Domain	MBOAT	MBOAT2 HHATL	2.98e-03	11	141	2	PF03062
Domain	MBOAT_fam	MBOAT2 HHATL	2.98e-03	11	141	2	IPR004299
Domain	-	VLDLR TENM4 ROS1	3.16e-03	39	141	3	2.120.10.30
Domain	Ferric_reduct	DUOX2 DUOX1	3.55e-03	12	141	2	PF01794
Domain	CENPB	POGK TIGD2	3.55e-03	12	141	2	SM00674
Domain	DDE_1	POGK TIGD2	3.55e-03	12	141	2	PF03184
Domain	Fe3_Rdtase_TM_dom	DUOX2 DUOX1	3.55e-03	12	141	2	IPR013130
Domain	DDE_SF_endonuclease_dom	POGK TIGD2	3.55e-03	12	141	2	IPR004875
Domain	HTH_CENPB	POGK TIGD2	4.18e-03	13	141	2	PS51253
Domain	HTH_Tnp_Tc5	POGK TIGD2	4.18e-03	13	141	2	PF03221
Domain	HTH_CenpB_DNA-bd_dom	POGK TIGD2	4.18e-03	13	141	2	IPR006600
Domain	-	ABCC1 NDST1 DNAH3 SPEF2 DNAH2 ABCC11 DHX57 MSH2 RRAGB AAGAB DNAH1 DYNC1H1 DNAH11	4.29e-03	746	141	13	3.40.50.300
Domain	6-blade_b-propeller_TolB-like	VLDLR TENM4 ROS1	5.04e-03	46	141	3	IPR011042
Domain	LY	VLDLR ROS1	5.57e-03	15	141	2	SM00135
Domain	LDLR_classB_rpt	VLDLR ROS1	5.57e-03	15	141	2	IPR000033
Pathway	KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT	DNAH3 TUBB8 DNAH2 DNAH1 DNAH17 DNAH11	1.17e-06	43	114	6	M47669
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH3 TUBB8 DNAH2 DNAH1 DNAH17 DNAH11	1.54e-06	45	114	6	M47670
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH3 DNAH2 DNAH1 DNAH17 DNAH11	2.22e-06	27	114	5	M47755
Pathway	REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION	IGKV1-39 ITK IGLC2 IGLC3 IGKV1D-39 IGKV3-11	6.81e-05	86	114	6	M27206
Pathway	REACTOME_ADAPTIVE_IMMUNE_SYSTEM	IGKV1-39 TPP2 KLHL2 WAS NEDD4L HLA-B BTNL8 TUBB8 ITK PSMD6 KLHL5 LMO7 IGLC2 IGLC3 IGKV1D-39 DYNC1H1 IGKV3-11 DYNC1I2	1.11e-04	828	114	18	M1058
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGKV1-39 IGLC2 IGLC3 IGKV1D-39 IGKV3-11	1.31e-04	61	114	5	M27581
Pathway	REACTOME_FCGR_ACTIVATION	IGKV1-39 IGLC2 IGLC3 IGKV1D-39 IGKV3-11	2.36e-04	69	114	5	M27108
Pathway	REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA	IGKV1-39 IGLC2 IGLC3 IGKV1D-39 IGKV3-11	2.36e-04	69	114	5	M27150
Pathway	REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS	IGKV1-39 IGLC2 IGLC3 IGKV1D-39 IGKV3-11	2.70e-04	71	114	5	M1078
Pathway	REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION	IGKV1-39 IGLC2 IGLC3 IGKV1D-39 IGKV3-11	2.70e-04	71	114	5	M27203
Pathway	REACTOME_PARASITE_INFECTION	IGKV1-39 WAS IGLC2 IGLC3 IGKV1D-39 IGKV3-11	3.53e-04	116	114	6	M29843
Pubmed	Organization and complete sequence of identical embryonic and plasmacytoma kappa V-region genes.	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 IGKV1D-43 IGKV1D-39 IGKV1D-8	1.30e-14	11	161	7	6767723
Pubmed	Amino acid sequence of the variable region of M149 mouse myeloma light chain: comparison with the nucleotide sequence of K2 and K3 clones.	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 IGKV1D-43 IGKV1D-39 IGKV1D-8	1.30e-14	11	161	7	6795447
Pubmed	Multiple related immunoglobulin variable-region genes identified by cloning and sequence analysis.	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 IGKV1D-43 IGKV1D-39 IGKV1D-8	1.30e-14	11	161	7	279004
Pubmed	Human myeloperoxidase in innate and acquired immunity.	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 IGKV1D-43 IGKV1D-39 IGKV1D-8	1.22e-12	18	161	7	20399194
Pubmed	Characteristics of the immunoglobulin Vkappa genes, pseudogenes, relics and orphons in the mouse genome.	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 IGKV1D-43 IGKV1D-39 IGKV1D-8	2.94e-12	20	161	7	10427970
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH3 DNAH2 DNAH1 DNAH17 DYNC1H1 DNAH11	2.61e-11	14	161	6	9373155
Pubmed	Structure and function of immunoglobulins.	IGLC7 IGLC1 IGLC2 IGLC3 IGLC6	5.78e-09	15	161	5	20176268
Pubmed	Isolation of several human axonemal dynein heavy chain genes: genomic structure of the catalytic site, phylogenetic analysis and chromosomal assignment.	DNAH3 DNAH2 DNAH1 DNAH11	1.53e-08	7	161	4	9256245
Pubmed	Human immunoglobulin C lambda 6 gene encodes the Kern+Oz-lambda chain and C lambda 4 and C lambda 5 are pseudogenes.	IGLC1 IGLC2 IGLC3 IGLC6	3.05e-08	8	161	4	3122211
Pubmed	Clustered arrangement of immunoglobulin lambda constant region genes in man.	IGLC1 IGLC2 IGLC3 IGLC6	5.47e-08	9	161	4	6273747
Pubmed	Structure and expression of the human immunoglobulin lambda genes.	IGLC7 IGLC1 IGLC2 IGLC3	5.47e-08	9	161	4	2115572
Pubmed	Physicochemical and functional characterization of the C1r subunit of the first complement component.	IGLC7 IGKV3D-11 IGLC1 IGLC2 IGLC3 IGLC6	8.22e-08	47	161	6	814163
Pubmed	Recognition of immunoglobulins by Fcgamma receptors.	IGLC7 IGKV3D-11 IGLC1 IGLC2 IGLC3 IGLC6	9.36e-08	48	161	6	11955599
Pubmed	Unraveling of the polymorphic C lambda 2-C lambda 3 amplification and the Ke+Oz- polymorphism in the human Ig lambda locus.	IGLC1 IGLC2 IGLC3	9.74e-08	3	161	3	12077254
Pubmed	Phosphatidylinositol transfer proteins regulate megakaryocyte TGF-β1 secretion and hematopoiesis in mice.	TGFB1 PITPNA PITPNB	9.74e-08	3	161	3	30042096
Pubmed	Three-dimensional structure of a light chain dimer crystallized in water. Conformational flexibility of a molecule in two crystal forms.	IGLC1 IGLC2 IGLC3	9.74e-08	3	161	3	2515285
Pubmed	Wiskott-Aldrich syndrome protein (WASp) controls the delivery of platelet transforming growth factor-β1.	WAS GSN TGFB1	9.74e-08	3	161	3	24133214
Pubmed	Evolution of the Autism-Associated Neuroligin-4 Gene Reveals Broad Erosion of Pseudoautosomal Regions in Rodents.	NLGN4Y NLGN3 NLGN4X	9.74e-08	3	161	3	32011705
Pubmed	Analysis of the neuroligin 4Y gene in patients with autism.	NLGN4Y NLGN3 NLGN4X	9.74e-08	3	161	3	18628683
Pubmed	Primary structure of the Mcg lambda chain.	IGLC1 IGLC2 IGLC3	3.88e-07	4	161	3	4415202
Pubmed	The three-dimensional structure of the fab' fragment of a human myeloma immunoglobulin at 2.0-angstrom resolution.	IGLC1 IGLC2 IGLC3	3.88e-07	4	161	3	4215080
Pubmed	Immunoglobulin lambda-chains. The complete amino acid sequence of a Bence-Jones protein.	IGLC1 IGLC2 IGLC3	3.88e-07	4	161	3	4883841
Pubmed	Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.	NLGN4Y NLGN3 NLGN4X	3.88e-07	4	161	3	12669065
Pubmed	Comparative studies on the structure of the light chains of human immunoglobulins. IV. Assignment of a subsubgroup.	IGLC1 IGLC2 IGLC3	3.88e-07	4	161	3	6404900
Pubmed	Homodimerization and isoform-specific heterodimerization of neuroligins.	NLGN4Y NLGN3 NLGN4X	3.88e-07	4	161	3	22671294
Pubmed	Ultrasonic vocalizations in mouse models for speech and socio-cognitive disorders: insights into the evolution of vocal communication.	NLGN4Y NLGN3 NLGN4X	3.88e-07	4	161	3	20579107
Pubmed	[Structural rule of antibodies. Primary structure of a monoclonal immunoglobulin-L-chain of the lambda type, subgroup IV (Bence-Jones-protein Kern). V. The complete amino acid sequence and its genetic interpretation].	IGLC1 IGLC2 IGLC3	3.88e-07	4	161	3	5549568
Pubmed	Analysis of four neuroligin genes as candidates for autism.	NLGN4Y NLGN3 NLGN4X	3.88e-07	4	161	3	16077734
Pubmed	Neuroligins 3 and 4X interact with syntrophin-gamma2, and the interactions are affected by autism-related mutations.	NLGN4Y NLGN3 NLGN4X	3.88e-07	4	161	3	17292328
Pubmed	Amino acid sequence of the (lambda) light chain of a human myeloma immunoglobulin (IgG New).	IGLC1 IGLC2 IGLC3	9.67e-07	5	161	3	4814727
Pubmed	Synapse formation: if it looks like a duck and quacks like a duck ...	NLGN4Y NLGN3 NLGN4X	9.67e-07	5	161	3	10996085
Pubmed	The amino acid sequence of a lambda type Bence-Jones protein. 3. The complete amino acid sequence and the location of the disulfide bridges.	IGLC1 IGLC2 IGLC3	9.67e-07	5	161	3	4909564
Pubmed	Multiple N-linked glycosylation sites critically modulate the synaptic abundance of neuroligin isoforms.	NLGN4Y NLGN3 NLGN4X	9.67e-07	5	161	3	37865312
Pubmed	The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?	NLGN4Y NLGN3 NLGN4X	1.93e-06	6	161	3	21838267
Pubmed	Autism-associated neuroligin-4 mutation selectively impairs glycinergic synaptic transmission in mouse brainstem synapses.	NLGN4Y NLGN3 NLGN4X	1.93e-06	6	161	3	29724786
Pubmed	Mutations in DNAH17, Encoding a Sperm-Specific Axonemal Outer Dynein Arm Heavy Chain, Cause Isolated Male Infertility Due to Asthenozoospermia.	DNAH2 DNAH17 DNAH11	3.36e-06	7	161	3	31178125
Pubmed	Prox1 ablation in hepatic progenitors causes defective hepatocyte specification and increases biliary cell commitment.	HNF1B SPP1 APOC2 ACVR2A TGFB1	3.58e-06	50	161	5	24449835
Pubmed	Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.	IGKV1-39 GSN TGFB1 IGKV3D-11 IGLC1 IGLC2 IGLC3	4.93e-06	143	161	7	22516433
Pubmed	Characterization of the two unique human anti-flavin monoclonal immunoglobulins.	IGLC1 IGLC2 IGLC3	5.36e-06	8	161	3	7737190
Pubmed	Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways.	NLGN4Y NLGN3 NLGN4X	5.36e-06	8	161	3	30871858
Pubmed	Using mouse models of autism spectrum disorders to study the neurotoxicology of gene-environment interactions.	NLGN4Y NLGN3 NLGN4X	8.01e-06	9	161	3	23010509
Pubmed	Ihh signaling regulates mandibular symphysis development and growth.	SPP1 PTCH1 TGFB1	8.01e-06	9	161	3	21297010
Pubmed	Dynein and kinesin regulate stress-granule and P-body dynamics.	DNAH2 DNAH1 DYNC1H1	1.14e-05	10	161	3	19825938
Pubmed	Pancreas-specific deletion of Prox1 affects development and disrupts homeostasis of the exocrine pancreas.	HNF1B SPP1 CELA3B CELA3A	1.26e-05	31	161	4	22178591
Pubmed	14-3-3ε mediates the cell fate decision-making pathways in response of hepatocellular carcinoma to Bleomycin-induced DNA damage.	CAD IVNS1ABP JAK1 SF3B1 LMO7	1.42e-05	66	161	5	23472066
Pubmed	Behavioral phenotypes of genetic mouse models of autism.	NLGN4Y NLGN3 NLGN4X	1.56e-05	11	161	3	26403076
Pubmed	SPARCL1 Promotes Excitatory But Not Inhibitory Synapse Formation and Function Independent of Neurexins and Neuroligins.	NLGN4Y NLGN3 NLGN4X	1.56e-05	11	161	3	32973045
Pubmed	Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism.	DUOX2 DUOX1	2.13e-05	2	161	2	28633507
Pubmed	TGF-β induces ST2 and programs ILC2 development.	TGFB1 IL1RL1	2.13e-05	2	161	2	31911623
Pubmed	Krüppel-like factor 6 regulates transforming growth factor-β gene expression during human respiratory syncytial virus infection.	KLF6 TGFB1	2.13e-05	2	161	2	21849067
Pubmed	Mice defective in the mismatch repair gene Msh2 show increased predisposition to UVB radiation-induced skin cancer.	XPC MSH2	2.13e-05	2	161	2	12531020
Pubmed	A substitution involving the NLGN4 gene associated with autistic behavior in the Greek population.	NLGN3 NLGN4X	2.13e-05	2	161	2	19645625
Pubmed	Osteopontin expression is required for myofibroblast differentiation.	SPP1 TGFB1	2.13e-05	2	161	2	18079410
Pubmed	Reactive oxygen species regulate the levels of dual oxidase (Duox1-2) in human neuroblastoma cells.	DUOX2 DUOX1	2.13e-05	2	161	2	22523549
Pubmed	Expression of dual oxidases and secreted cytokines in chronic rhinosinusitis.	DUOX2 DUOX1	2.13e-05	2	161	2	23281318
Pubmed	Specific and nonspecific membrane-binding determinants cooperate in targeting phosphatidylinositol transfer protein beta-isoform to the mammalian trans-Golgi network.	PITPNA PITPNB	2.13e-05	2	161	2	16540520
Pubmed	Uncoupling of growth plate maturation and bone formation in mice lacking both Schnurri-2 and Schnurri-3.	HIVEP2 HIVEP3	2.13e-05	2	161	2	20404140
Pubmed	Host-derived TGFB1 deficiency suppresses lesion development in a mouse model of endometriosis.	TGFB1 PRKDC	2.13e-05	2	161	2	22210480
Pubmed	Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism.	NLGN4Y NLGN4X	2.13e-05	2	161	2	23183221
Pubmed	Involvement of gelsolin in TGF-beta 1 induced epithelial to mesenchymal transition in breast cancer cells.	GSN TGFB1	2.13e-05	2	161	2	26482896
Pubmed	Overexpression of osteopontin in clear cell carcinoma of the ovary: close association with HNF-1beta expression.	HNF1B SPP1	2.13e-05	2	161	2	18393978
Pubmed	Genetic ablation of phosphatidylinositol transfer protein function in murine embryonic stem cells.	PITPNA PITPNB	2.13e-05	2	161	2	11907258
Pubmed	Phage display of a human antibody against Clostridium tetani toxin.	IGKV1-39 IGKV1D-39	2.13e-05	2	161	2	7926831
Pubmed	Conserved cysteine residues provide a protein-protein interaction surface in dual oxidase (DUOX) proteins.	DUOX2 DUOX1	2.13e-05	2	161	2	23362256
Pubmed	Osteopontin May Improve Postinjury Muscle Repair Via Matrix Metalloproteinases And tgf-β Activation in Regular Exercise.	SPP1 TGFB1	2.13e-05	2	161	2	37575268
Pubmed	Hedgehog-independent overexpression of transforming growth factor-beta1 in rhabdomyosarcoma of Patched1 mutant mice.	PTCH1 TGFB1	2.13e-05	2	161	2	17611698
Pubmed	CircHYBID regulates hyaluronan metabolism in chondrocytes via hsa-miR-29b-3p/TGF-β1 axis.	CEMIP TGFB1	2.13e-05	2	161	2	34058990
Pubmed	Characterization of ThOX proteins as components of the thyroid H(2)O(2)-generating system.	DUOX2 DUOX1	2.13e-05	2	161	2	11822874
Pubmed	No evidence for involvement of genetic variants in the X-linked neuroligin genes NLGN3 and NLGN4X in probands with autism spectrum disorder on high functioning level.	NLGN3 NLGN4X	2.13e-05	2	161	2	18189281
Pubmed	Dual oxidase 1 and 2 expression in airway epithelium of smokers and patients with mild/moderate chronic obstructive pulmonary disease.	DUOX2 DUOX1	2.13e-05	2	161	2	18177232
Pubmed	An isoform of the phosphatidylinositol-transfer protein transfers sphingomyelin and is associated with the Golgi system.	PITPNA PITPNB	2.13e-05	2	161	2	7654206
Pubmed	Neuronal migration defects in the Loa dynein mutant mouse.	DNAH1 DYNC1H1	2.13e-05	2	161	2	21612657
Pubmed	Thrombin-activatable carboxypeptidase B cleavage of osteopontin regulates neutrophil survival and synoviocyte binding in rheumatoid arthritis.	CPA6 SPP1	2.13e-05	2	161	2	19790060
Pubmed	Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense.	DUOX2 DUOX1	2.13e-05	2	161	2	12824283
Pubmed	Null mutation in transforming growth factor beta1 disrupts ovarian function and causes oocyte incompetence and early embryo arrest.	TGFB1 PRKDC	2.13e-05	2	161	2	16269452
Pubmed	Roles of DUOX-mediated hydrogen peroxide in metabolism, host defense, and signaling.	DUOX2 DUOX1	2.13e-05	2	161	2	24161126
Pubmed	Down-regulation of osteopontin mediates a novel mechanism underlying the cytostatic activity of TGF-β.	SPP1 TGFB1	2.13e-05	2	161	2	26584547
Pubmed	Unusually rapid evolution of Neuroligin-4 in mice.	NLGN4Y NLGN4X	2.13e-05	2	161	2	18434543
Pubmed	Platelet releasates promote the proliferation of hepatocellular carcinoma cells by suppressing the expression of KLF6.	KLF6 TGFB1	2.13e-05	2	161	2	28638139
Pubmed	Analysis of the genes encoding neuroligins NLGN3 and NLGN4 in Bulgarian patients with autism.	NLGN3 NLGN4X	2.13e-05	2	161	2	23431752
Pubmed	Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice.	NLGN4Y NLGN4X	2.13e-05	2	161	2	37080762
Pubmed	Cloning and expression of human cDNA encoding phosphatidylinositol transfer protein beta.	PITPNA PITPNB	2.13e-05	2	161	2	8541325
Pubmed	Phospholipid transfer proteins.	PITPNA PITPNB	2.13e-05	2	161	2	1883207
Pubmed	Autism Related Neuroligin-4 Knockout Impairs Intracortical Processing but not Sensory Inputs in Mouse Barrel Cortex.	NLGN4Y NLGN4X	2.13e-05	2	161	2	29106499
Pubmed	Perturbed Hippocampal Synaptic Inhibition and γ-Oscillations in a Neuroligin-4 Knockout Mouse Model of Autism.	NLGN4Y NLGN4X	2.13e-05	2	161	2	26456829
Pubmed	Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro.	NLGN4Y NLGN4X	2.13e-05	2	161	2	24104404
Pubmed	Angiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomes.	TGFB1 JAK1	2.13e-05	2	161	2	26586478
Pubmed	Differential regulation of dual NADPH oxidases/peroxidases, Duox1 and Duox2, by Th1 and Th2 cytokines in respiratory tract epithelium.	DUOX2 DUOX1	2.13e-05	2	161	2	16111680
Pubmed	Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4.	NLGN4Y NLGN4X	2.13e-05	2	161	2	22989184
Pubmed	Nox/Duox family of nicotinamide adenine dinucleotide (phosphate) oxidases.	DUOX2 DUOX1	2.13e-05	2	161	2	11753072
Pubmed	Regulated hydrogen peroxide production by Duox in human airway epithelial cells.	DUOX2 DUOX1	2.13e-05	2	161	2	15677770
Pubmed	Variations analysis of NLGN3 and NLGN4X gene in Chinese autism patients.	NLGN3 NLGN4X	2.13e-05	2	161	2	24570023
Pubmed	Mucosal reactive oxygen species are required for antiviral response: role of Duox in influenza a virus infection.	DUOX2 DUOX1	2.13e-05	2	161	2	24128054
Pubmed	Identification of a novel class of elastase isozyme, human pancreatic elastase III, by cDNA and genomic gene cloning.	CELA3B CELA3A	2.13e-05	2	161	2	2826474
Pubmed	The Role of Lipin-1 in the Regulation of Fibrogenesis and TGF-β Signaling in Hepatic Stellate Cells.	TGFB1 LPIN1	2.13e-05	2	161	2	27345520
Pubmed	Association Analysis of Noncoding Variants in Neuroligins 3 and 4X Genes with Autism Spectrum Disorder in an Italian Cohort.	NLGN3 NLGN4X	2.13e-05	2	161	2	27782075
Pubmed	Not all neuroligin 3 and 4X missense variants lead to significant functional inactivation.	NLGN3 NLGN4X	2.13e-05	2	161	2	28948087
Pubmed	Delayed wound healing in immunodeficient TGF-beta 1 knockout mice.	TGFB1 PRKDC	2.13e-05	2	161	2	10886500
Pubmed	Genetic Analysis of Human Chymotrypsin-Like Elastases 3A and 3B (CELA3A and CELA3B) to Assess the Role of Complex Formation between Proelastases and Procarboxypeptidases in Chronic Pancreatitis.	CELA3B CELA3A	2.13e-05	2	161	2	27999401
Pubmed	Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism.	NLGN3 NLGN4X	2.13e-05	2	161	2	16648374
Cytoband	2p12	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 IGKV3D-11 IGKV1D-43 IGKV1D-39 IGKV1D-8 IGKV3-11	3.83e-10	117	161	9	2p12
Cytoband	Ensembl 112 genes in cytogenetic band chr2p11	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 IGKV3D-11 IGKV1D-43 IGKV1D-39 IGKV1D-8 IGKV3-11	7.29e-08	213	161	9	chr2p11
Cytoband	22q11.2	IGLV3-10 IGLC7 IGLC1 IGLC2 IGLC3 IGLC6	4.45e-06	120	161	6	22q11.2
Cytoband	1p36.12	FAM43B CELA3B CELA3A	3.53e-04	39	161	3	1p36.12
Cytoband	6q23-q24	HIVEP2 VNN2	4.33e-04	9	161	2	6q23-q24
Cytoband	Ensembl 112 genes in cytogenetic band chr5q33	NDST1 SLC36A1 ITK THG1L	8.20e-04	118	161	4	chr5q33
Cytoband	19q13.1	TGFB1 FCGBP CATSPERG	9.71e-04	55	161	3	19q13.1
GeneFamily	Immunoglobulin kappa locus at 2p11.2	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 IGKV3D-11 IGKV1D-43 IGKV1D-39 IGKV1D-8 IGKV3-11	2.97e-09	83	116	9	351
GeneFamily	Dyneins, axonemal	DNAH3 DNAH2 DNAH1 DNAH17 DNAH11	5.80e-08	17	116	5	536
GeneFamily	Fibronectin type III domain containing	EPOR NCAM2 FNDC7 PTPRO PTPRQ ASTN2 ROS1 SDK1	8.93e-06	160	116	8	555
GeneFamily	Immunoglobulin lambda locus at 22q11.2	IGLV3-10 IGLC7 IGLC1 IGLC2 IGLC3 IGLC6	2.31e-05	89	116	6	353
GeneFamily	HNF class homeoboxes	HMBOX1 HNF1B	1.22e-04	3	116	2	524
GeneFamily	Phosphatidylinositol transfer proteins	PITPNA PITPNB	6.02e-04	6	116	2	1151
GeneFamily	Membrane bound O-acyltransferases	MBOAT2 HHATL	8.39e-04	7	116	2	1036
GeneFamily	Kelch like\|BTB domain containing	KLHL2 IVNS1ABP KLHL5	2.46e-03	42	116	3	617
GeneFamily	Dyneins, cytoplasmic	DYNC1H1 DYNC1I2	3.04e-03	13	116	2	538
GeneFamily	Helix-turn-helix CENPB type domain containing	POGK TIGD2	3.04e-03	13	116	2	533
GeneFamily	ATP binding cassette subfamily C	ABCC1 ABCC11	3.04e-03	13	116	2	807
GeneFamily	CD molecules\|I-set domain containing\|Immunoglobulin like domain containing\|Interleukin receptors\|TIR domain containing	IL1RAPL1 IL1RL1	4.06e-03	15	116	2	1296
Coexpression	RASHI_RESPONSE_TO_IONIZING_RADIATION_6	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 CD48 IGKV1D-43 IGKV1D-39 IGKV1D-8	1.57e-06	132	160	8	MM996
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#3	IGKV1-39 IGKV1-27 IGKV1-9 OLFM4 FCGBP IGLC7 IGKV3D-11 CCR3 IGLC1 IGLC2 IGLC3 IGKV1D-39 IGKV3-11	7.28e-10	183	152	13	Arv_SC-HD_1000_K3
CoexpressionAtlas	AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500_k-means-cluster#2	IGKV1-39 IGKV1-27 IGKV1-9 OLFM4 FCGBP IGLC7 IGKV3D-11 IGLC1 IGLC2 IGLC3 IGKV1D-39 IGKV3-11	2.24e-09	163	152	12	Arv_SC-hpx_blastocyst_500_K2
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500_k-means-cluster#3	IGKV1-39 IGKV1-27 IGKV1-9 OLFM4 FCGBP IGLC7 IGKV3D-11 IGLC1 IGLC2 IGLC3 IGKV1D-39 IGKV3-11	5.03e-09	175	152	12	Arv_SC-H9hpx_500_K3
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#5	IGKV1-39 IGKV1-27 IGKV1-9 OLFM4 FCGBP IGLC7 IGKV3D-11 IGLC1 IGLC2 IGLC3 IGKV1D-39 IGKV3-11	8.33e-09	183	152	12	Arv_SC_fibroblast_1000_K5
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500_k-means-cluster#3	IGKV1-39 AGR2 OLFM4 FCGBP IGLC7 IGLC1 IGLC2 IGLC3 IGKV1D-39 IGKV3-11	6.35e-08	139	152	10	Arv_SC_fibroblast_500_K3
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_500_k-means-cluster#2	IGKV1-39 OLFM4 FCGBP IGLC7 IGLC1 IGLC2 IGLC3 IGKV1D-39 IGKV3-11	3.14e-07	126	152	9	Arv_SC-HD_500_K2
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#4	IGKV1-39 IGKV1-27 IGKV1-9 OLFM4 FCGBP IGLC7 IGKV3D-11 IGLC1 IGLC2 IGKV1D-39 IGKV3-11	1.53e-06	244	152	11	Arv_SC-H9hpx_1000_K4
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500	IGKV1-39 IGKV1-27 IGKV1-9 AGR2 OLFM4 FCGBP NLGN4X IGLC7 IGKV3D-11 IGLC1 IGLC2 IGLC3 IGKV1D-39 IGKV3-11	1.26e-05	492	152	14	Arv_SC-H9hpx_500
CoexpressionAtlas	AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500	IGKV1-39 IGKV1-27 IGKV1-9 AGR2 OLFM4 FCGBP NLGN4X IGLC7 IGKV3D-11 IGLC1 IGLC2 IGLC3 IGKV1D-39 IGKV3-11	1.26e-05	492	152	14	Arv_SC-hpx_blastocyst_500
CoexpressionAtlas	AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#2	IGKV1-39 IGKV1-27 IGKV1-9 AGR2 OLFM4 FCGBP IGLC7 IGKV3D-11 IGKV1D-39 IGKV3-11	2.27e-05	266	152	10	Arv_SC-hpx_blastocyst_1000_K2
ToppCell	COPD-Lymphoid-B_Plasma\|World / Disease state, Lineage and Cell class	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 IGLV3-10 LPIN1 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGLC6 IGKV1D-39 IGKV1D-8 IGKV3-11	3.01e-15	175	160	14	d73ee324479172501481b54967a0f3bd870fcf3a
ToppCell	Biopsy_IPF-Immune-Plasma_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 PKHD1L1 IGLV3-10 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGKV1D-43 IGKV1D-39 IGKV1D-8 IGKV3-11	1.46e-14	196	160	14	a1b6a8000b86efcb07843998aa3a49bb1f54bcda
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-9 IGKV1-8 PKHD1L1 IGLV3-10 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGLC6 IGKV1D-39 IGKV1D-8 IGKV3-11	1.41e-13	183	160	13	cf5c98f451a568308c52da5c926543dd4836c6b2
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-9 IGKV1-8 PKHD1L1 IGLV3-10 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGLC6 IGKV1D-39 IGKV1D-8 IGKV3-11	1.62e-13	185	160	13	6ec009e48e50471c28e914c402f500e56a88f8f2
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-9 IGKV1-8 PKHD1L1 IGLV3-10 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGLC6 IGKV1D-39 IGKV1D-8 IGKV3-11	1.62e-13	185	160	13	f49ad6401b2abd089e30eba245b11b5031ea2318
ToppCell	5'-Adult-LargeIntestine-Hematopoietic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 TGFB1 IGLV3-10 IGKV3D-11 IGLC2 IGLC3 IGKV1D-43 IGKV1D-39 IGKV1D-8 IGKV3-11	2.45e-13	191	160	13	d1d30279ed4612b4f62c225d9eabf0b8a7a09d11
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGLC6 IGKV1D-43 IGKV1D-39 IGKV1D-8 IGKV3-11	3.20e-13	195	160	13	f3f7f1a77a1edd2b50a8211c76fe289738eb04cf
ToppCell	normal_Lung-B_lymphocytes-MALT_B_cells\|normal_Lung / Location, Cell class and cell subclass	IGKV1-39 IGKV1-9 IGKV1-8 PKHD1L1 IGLC7 IGLC2 IGLC3 IGLC6 IGKV1D-43 IGKV1D-39 IGKV1D-8 IGKV3-11	6.11e-13	159	160	12	fbd0131b66f4267f7b0d6c3ad874ad097b859074
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-27 IGKV1-8 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGLC6 IGKV1D-43 IGKV1D-39 IGKV1D-8 IGKV3-11	1.67e-12	173	160	12	7e6bfe85f60834f317941b70d6e0dc3bd527d293
ToppCell	metastatic_Brain-B_lymphocytes-MALT_B_cells\|metastatic_Brain / Location, Cell class and cell subclass	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 PKHD1L1 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGLC6 IGKV1D-39 IGKV3-11	2.05e-12	176	160	12	50e207403d48ce1b55a78897adb5519a2430a626
ToppCell	IPF-Lymphoid-B_Plasma\|IPF / Disease state, Lineage and Cell class	IGKV1-39 IGKV1-8 IGLV3-10 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGLC6 IGKV1D-43 IGKV1D-39 IGKV1D-8 IGKV3-11	2.05e-12	176	160	12	e4f33f6cd140dd4fa3002bcd65ac8005d27865d1
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 IGLV3-10 IGKV3D-11 IGLC2 IGLC3 IGKV1D-43 IGKV1D-39 IGKV1D-8 IGKV3-11	5.06e-12	190	160	12	79ee6d10dfbb775da149a1104da5823cf63bbb46
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 IGLV3-10 IGKV3D-11 IGLC2 IGLC3 IGKV1D-43 IGKV1D-39 IGKV1D-8 IGKV3-11	5.06e-12	190	160	12	18762ce78ed0b206ade19e1c8ff76a2647489f68
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGKV1D-43 IGKV1D-39 IGKV1D-8 IGKV3-11	6.47e-12	194	160	12	6ef4aeb8d8e35e4df58ff2a8256caa2113291de9
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGKV1D-43 IGKV1D-39 IGKV1D-8 IGKV3-11	7.75e-12	197	160	12	9fe1b757f76c2d43d39aa9ac500eaba98723985c
ToppCell	368C-Lymphocytic-Plasma_cell-\|368C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-8 PKHD1L1 IGLV3-10 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGLC6 IGKV1D-39 IGKV1D-8	1.83e-11	162	160	11	c21a54310b239d999bbc9d8fb5e8fda16e0bc336
ToppCell	368C-Lymphocytic-Plasma_cell\|368C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-8 PKHD1L1 IGLV3-10 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGLC6 IGKV1D-39 IGKV1D-8	1.83e-11	162	160	11	f945688815229c8386cbcbf46deee7df316fa8d3
ToppCell	tumor_Lung-B_lymphocytes-Plasma_cells\|tumor_Lung / Location, Cell class and cell subclass	IGKV1-27 IGKV1-9 IGKV1-8 PKHD1L1 IGLV3-10 IGLC7 IGLC2 IGLC3 IGLC6 IGKV1D-39 IGKV3-11	2.89e-11	169	160	11	b36b7632ce55fc7b6b8b66020563d360b3de6fd7
ToppCell	metastatic_Brain-B_lymphocytes-Plasma_cells\|metastatic_Brain / Location, Cell class and cell subclass	IGKV1-27 IGKV1-9 PKHD1L1 IGLC7 IGLC2 IGLC3 IGLC6 IGKV1D-43 IGKV1D-39 IGKV1D-8 IGKV3-11	3.08e-11	170	160	11	53634da9e9c72f6400639954c286c6e38ea5a188
ToppCell	Control-Lymphoid-B_Plasma\|Control / Disease state, Lineage and Cell class	IGKV1-39 TTC41P IGLC7 IGKV3D-11 IGLC2 IGLC3 IGLC6 IGKV1D-43 IGKV1D-39 IGKV1D-8 IGKV3-11	3.50e-11	172	160	11	61e33836b8cb0f347f3e699eb587a37073b6fa4c
ToppCell	Plasma_cells\|World / lung cells shred on cell class, cell subclass, sample id	IGKV1-39 IGKV1-9 IGKV1-8 PKHD1L1 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGKV1D-39 IGKV1D-8 IGKV3-11	3.73e-11	173	160	11	52a387e2a4694af61a9223a4c2ecf4e6f762c064
ToppCell	(2)_Plasma_cells\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	IGKV1-39 IGKV1-8 PKHD1L1 IGLV3-10 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGKV1D-39 IGKV1D-8 IGKV3-11	4.77e-11	177	160	11	ed3c936bb69f9bc7291b4f6cde1d204078117c48
ToppCell	-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	IGKV1-39 IGKV1-9 IGKV1-8 SPP1 PKHD1L1 IGLV3-10 IGLC2 IGLC3 IGKV1D-39 IGKV1D-8 IGKV3-11	4.77e-11	177	160	11	ae2d2e138946535596fa30a55207f261cafda461
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-39 IGKV1-9 IGKV1-8 IGLV3-10 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGKV1D-39 IGKV1D-8 IGKV3-11	5.38e-11	179	160	11	494febe77c6d4e6a2c6f0928bbf4c84b0301f188
ToppCell	10x5'-Lung-Lymphocytic_B\|Lung / Manually curated celltypes from each tissue	IGKV1-39 IGKV1-8 PKHD1L1 IGLV3-10 NLGN4X IGLC1 IGLC2 IGLC3 IGKV1D-39 IGKV1D-8 IGKV3-11	6.44e-11	182	160	11	310f94437d197eaaaf6e30e68063b33e94befe77
ToppCell	cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGKV1-39 IGKV1-8 IGLC7 IGKV3D-11 IGLC1 IGLC2 IGLC3 IGLC6 IGKV1D-39 IGKV1D-8 IGKV3-11	6.83e-11	183	160	11	5ab4aa0304b832f98fff89b6c24ad5b7dd014c11
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 PKHD1L1 IGLC7 IGLC2 IGLC3 IGKV1D-39 IGKV1D-8 IGKV3-11	7.68e-11	185	160	11	0fff2608f507e019ebb69c27e58fd5be3b049bef
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 PKHD1L1 IGLC7 IGLC2 IGLC3 IGKV1D-39 IGKV1D-8 IGKV3-11	7.68e-11	185	160	11	79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-9 IGKV1-8 PKHD1L1 IGLV3-10 IGLC7 IGLC2 IGLC3 IGLC6 IGKV1D-39 IGKV1D-8	1.35e-10	195	160	11	2d18f08f33f3b261c77b8adf87d1a184cc6d7400
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell-IgG_Plasmablast\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGKV1D-39 IGKV1D-8 IGKV3-11	1.51e-10	197	160	11	b754fad4f3caae6de95df901fd96ea8697fe41b1
ToppCell	390C-Lymphocytic-Plasma_cell-\|390C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-9 IGKV1-8 PKHD1L1 IGLC7 IGLC2 IGLC3 IGLC6 IGKV1D-43 IGKV1D-8	2.73e-10	156	160	10	4f92ca30755430db44402afc603d1ecd8bfc3617
ToppCell	390C-Lymphocytic-Plasma_cell\|390C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-9 IGKV1-8 PKHD1L1 IGLC7 IGLC2 IGLC3 IGLC6 IGKV1D-43 IGKV1D-8	2.73e-10	156	160	10	0de2fc695bd5f8d4633c514f71ea941c88137bac
ToppCell	Control-Lymphoid-B_Plasma\|World / Disease state, Lineage and Cell class	IGKV1-39 TTC41P IGLC7 IGKV3D-11 IGLC2 IGLC3 IGLC6 IGKV1D-43 IGKV1D-39 IGKV3-11	6.34e-10	170	160	10	fb05f49b7113470995b3c16683c54dc1a660b73a
ToppCell	wk_08-11-Hematologic_Lymphocytic-B\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	IGKV1-39 IGKV1-8 HLA-B IGKV3D-11 IGLC2 IGLC3 IGKV1D-43 IGKV1D-39 IGKV1D-8 IGKV3-11	7.11e-10	172	160	10	d1ab8f493b70ec995281f9fb0991f1d3aa7b928f
ToppCell	Control-Lymphoid_P-Plasmablast\|Control / Disease group, lineage and cell class	IGKV1-27 IGKV1-9 IGKV1-8 PKHD1L1 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGKV1D-39 IGKV3-11	8.90e-10	176	160	10	4b4416f342b732d2cc60133838728880326257d8
ToppCell	Control-Lymphoid_P\|Control / Disease group, lineage and cell class	IGKV1-27 IGKV1-9 IGKV1-8 PKHD1L1 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGKV1D-39 IGKV3-11	8.90e-10	176	160	10	d895a6b295cd649273ff80ad7785a3e0ae4c728a
ToppCell	COPD-Lymphoid-B_Plasma\|COPD / Disease state, Lineage and Cell class	IGKV1-39 IGKV1-8 LPIN1 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGLC6 IGKV1D-39 IGKV1D-8	9.40e-10	177	160	10	1b872d3b1e0fca138362098590a634d748dfca60
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-9 IGKV1-8 IGLV3-10 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGKV1D-39 IGKV1D-8 IGKV3-11	1.05e-09	179	160	10	837ed81f18257f444eaeadc4fac89deedd4e3061
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-9 IGKV1-8 IGLV3-10 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGKV1D-39 IGKV1D-8 IGKV3-11	1.05e-09	179	160	10	b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f
ToppCell	cellseq-Immune-Lymphocytic_B-Lymphocytic_B\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGKV1-39 IGLC7 CD48 IGKV3D-11 IGLC1 IGLC2 IGLC3 IGLC6 IGKV1D-39 IGKV3-11	1.11e-09	180	160	10	cd04d7bf92986a5b8a0193c9b92ec47da3929bac
ToppCell	cellseq-Immune-Lymphocytic_B\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGKV1-39 IGLC7 CD48 IGKV3D-11 IGLC1 IGLC2 IGLC3 IGLC6 IGKV1D-39 IGKV3-11	1.11e-09	180	160	10	663a800ab70e7ab7d13183417f9c1ed36907aa5e
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFCAB6 NCAM2 PKHD1L1 DNAH1 SORCS1 TENM4 PTPRQ ROS1 SDK1 DNAH11	1.37e-09	184	160	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFCAB6 NCAM2 PKHD1L1 DNAH1 SORCS1 TENM4 PTPRQ ROS1 SDK1 DNAH11	1.37e-09	184	160	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFCAB6 NCAM2 PKHD1L1 DNAH1 SORCS1 TENM4 PTPRQ ROS1 SDK1 DNAH11	1.37e-09	184	160	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	10x5'-Liver-Lymphocytic_B_plasma-Plasma_cells\|Liver / Manually curated celltypes from each tissue	IGKV1-39 IGKV1-27 IGKV1-9 PKHD1L1 IGKV3D-11 IGLC1 IGLC2 IGLC3 IGKV1D-39 IGKV3-11	1.37e-09	184	160	10	6f70d8f8ab8362d51f8a58735d42223e06566397
ToppCell	wk_08-11-Hematologic_Lymphocytic-B-Immature_B\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	IGKV1-39 WAS HLA-B VNN2 CD48 IGKV3D-11 IGLC2 IGLC3 IGKV1D-39 IGKV3-11	1.37e-09	184	160	10	e6669a1b7ea7e4f8e094add5117689470019d85d
ToppCell	healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast\|healthy_donor / Disease condition, Lineage, Cell class and subclass	IGKV1-27 IGKV1-9 IGKV1-8 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGKV1D-43 IGKV1D-39 IGKV3-11	1.52e-09	186	160	10	e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67
ToppCell	Mild_COVID-19-B_cell-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IGKV1-39 IGKV1-9 IGKV1-8 PKHD1L1 IGLV3-10 IGKV3D-11 IGLC2 IGLC3 IGKV1D-39 IGKV1D-8	1.52e-09	186	160	10	855a5a00ba2aa1b5c63b8db56d026ddecc546050
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IGKV1-39 IGKV1-9 IGKV1-8 PKHD1L1 IGKV3D-11 IGLC2 IGLC3 IGKV1D-39 IGKV1D-8 IGKV3-11	1.78e-09	189	160	10	5a42be62552d912d0abf68f00d75ac80bbd69f2c
ToppCell	Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-8 PKHD1L1 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGLC6 IGKV1D-39 IGKV1D-8	2.07e-09	192	160	10	ca4d8e540d9e6fa47ecf97648cbd5abfc7ab7f85
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HNF1B EFCAB6 SLC6A16 OLFM4 DUOX2 TGM4 CELA3B PTPRQ ACCSL MMP17	2.17e-09	193	160	10	315840bc48899f3a36d57b19197509de19716e3d
ToppCell	COVID-19-Lymphoid-Plasma,_B_cells\|COVID-19 / Condition, Lineage and Cell class	IGKV1-39 IGKV1-9 IGKV1-8 PKHD1L1 IGKV3D-11 IGLC2 IGLC3 IGKV1D-39 IGKV1D-8 IGKV3-11	2.17e-09	193	160	10	bffd97a73365e1dd23ff3b0320b4860f04ec091a
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-27 IGKV1-9 IGKV1-8 IGKV3D-11 IGLC2 IGLC3 IGKV1D-43 IGKV1D-39 IGKV1D-8 IGKV3-11	2.17e-09	193	160	10	34f6c13884fdf7f8a87f942fcb36a58cfac3f65d
ToppCell	Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-27 IGKV1-8 PKHD1L1 IGLC7 IGLC2 IGLC3 IGLC6 IGKV1D-43 IGKV1D-39	2.29e-09	194	160	10	f902e7eb7e7fbb129c1a6e4160166f16798abaf6
ToppCell	Biopsy_Other_PF-Immune-Plasma_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	IGKV1-39 IGKV1-27 IGKV1-8 PKHD1L1 IGKV3D-11 IGLC2 IGLC3 IGKV1D-39 IGKV1D-8 IGKV3-11	2.40e-09	195	160	10	d0305c6a68c9e361507b04db94f86873085d49b3
ToppCell	metastatic_Lymph_Node-B_lymphocytes-Plasma_cells\|metastatic_Lymph_Node / Location, Cell class and cell subclass	IGKV1-27 IGKV1-9 IGLV3-10 IGKV3D-11 IGLC2 IGLC3 IGLC6 IGKV1D-39 IGKV3-11	2.42e-09	142	160	9	5ba3a33c2ee20be8baaed97536ca6e9d1de6752f
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-8 PKHD1L1 IGLV3-10 IGLC7 IGLC2 IGLC3 IGLC6 IGKV1D-39 IGKV1D-8	2.52e-09	196	160	10	b3d5540fe8ab9a9cbb9ab5350f5cb0e1aae93584
ToppCell	Control-Control-Lymphocyte-B-Plasmablast\|Control / Disease, condition lineage and cell class	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 PKHD1L1 IGLC7 IGLC2 IGLC3 IGKV1D-39 IGKV3-11	2.92e-09	199	160	10	c11aa8bca3723a886e7082ae48bb922dd8396be4
ToppCell	343B-Lymphocytic-Plasma_cell-\|343B / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-27 PKHD1L1 IGLC7 IGLC2 IGLC3 IGLC6 IGKV1D-39 IGKV1D-8	5.85e-09	157	160	9	554ddbaf83f5d6eb4669c673efdbb28fd87e2ba8
ToppCell	343B-Lymphocytic-Plasma_cell\|343B / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-27 PKHD1L1 IGLC7 IGLC2 IGLC3 IGLC6 IGKV1D-39 IGKV1D-8	5.85e-09	157	160	9	2cb3deb5313ce734710c601935ca318e4179077e
ToppCell	3'_v3-Lung-Lymphocytic_B_plasma-Plasma_cells\|Lung / Manually curated celltypes from each tissue	IGKV1-39 IGKV1-27 IGKV1-8 PKHD1L1 IGLC1 IGLC2 IGLC3 IGLC6 IGKV3-11	8.57e-09	164	160	9	3b6a32ba53d05f6818fe950ac426f489383b645a
ToppCell	390C-Lymphocytic-Plasma_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-9 IGKV1-8 PKHD1L1 IGLC7 IGLC2 IGLC6 IGKV1D-43 IGKV1D-8	9.53e-09	166	160	9	4ba3711a02d3695b27f7cefd7c60e3be009f5bef
ToppCell	390C-Lymphocytic-Plasma_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-9 IGKV1-8 PKHD1L1 IGLC7 IGLC2 IGLC6 IGKV1D-43 IGKV1D-8	9.53e-09	166	160	9	35f6ae2664935dda0d883b32a050ced843204f2d
ToppCell	367C-Lymphocytic-Plasma_cell-\|367C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGLC6 IGKV1D-43 IGKV1D-39 IGKV3-11	1.00e-08	167	160	9	f2185eb72f0137136f6d71af2a70168fded6c940
ToppCell	367C-Lymphocytic-Plasma_cell\|367C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGLC6 IGKV1D-43 IGKV1D-39 IGKV3-11	1.00e-08	167	160	9	5e768cf24699893e05d1bcb1c92dba2336943a64
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-39 IGKV1-9 IGKV1-8 PKHD1L1 IGLV3-10 IGLC7 IGLC2 IGLC3 IGKV1D-39	1.11e-08	169	160	9	307571e57c3bfdf15f0fe1a8b36585e8e4f8a207
ToppCell	3'_v3-bone_marrow-Lymphocytic_B_plasma-Plasma_cells\|bone_marrow / Manually curated celltypes from each tissue	IGKV1-39 PKHD1L1 IGKV3D-11 IGLC1 IGLC2 IGLC3 IGLC6 IGKV1D-39 IGKV3-11	1.51e-08	175	160	9	51301f3f44d3e88397f367cedd1e2abaa2be4c6f
ToppCell	IPF-Lymphoid-B_Plasma\|World / Disease state, Lineage and Cell class	IGKV1-39 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGLC6 IGKV1D-43 IGKV1D-8 IGKV3-11	1.59e-08	176	160	9	cc0cab6487df6867b529596ec94f55d31aa6ca36
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGKV1-9 IGKV1-8 IGLV3-10 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGKV1D-8 IGKV3-11	1.67e-08	177	160	9	4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGKV1-9 IGKV1-8 IGLV3-10 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGKV1D-8 IGKV3-11	1.67e-08	177	160	9	d746122bf8d208c3aa4d156e8c12d0a0e555c6e5
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGKV1-9 IGKV1-8 IGLV3-10 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGKV1D-8 IGKV3-11	1.67e-08	177	160	9	fc40918825b7e1eb6861df59dfca944778a64b98
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-9 IGKV1-8 IGKV3D-11 IGLC2 IGLC3 IGKV1D-39 IGKV1D-8 IGKV3-11	1.75e-08	178	160	9	107dae8b00c4257697a63700e72bb434cdb8406f
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 SPEF2 DNAH2 HHATL EFCAB12 SYT14 DLEC1 SDK1 DNAH11	1.84e-08	179	160	9	5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-27 IGKV1-9 IGKV1-8 IGLC7 IGLC2 IGLC3 IGLC6 IGKV1D-43 IGKV3-11	1.93e-08	180	160	9	cea079bc02e08c46600eed05ab9924ec90e1e3d3
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 IGKV3D-11 IGLC2 IGLC3 IGKV1D-43 IGKV3-11	2.02e-08	181	160	9	e47664a264a2c37390d1668ce04eef2e0172f4cb
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IGKV1-39 IGKV1-9 PKHD1L1 IGLC7 IGLC2 IGLC3 IGLC6 IGKV1D-8 IGKV3-11	2.02e-08	181	160	9	f7b08f662eb77ee7a777c6525ddc3195046aaf65
ToppCell	Mild-Lymphoid-B\|Mild / Condition, Lineage, Cell class and cell subclass	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 PKHD1L1 IGLC7 IGLC2 IGLC3 IGKV1D-39	2.22e-08	183	160	9	9b64d2d143525e6f48a191facfd101462ff36324
ToppCell	Mild_COVID-19-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IGKV1-39 IGKV1-9 IGKV1-8 PKHD1L1 IGKV3D-11 IGLC2 IGLC3 IGKV1D-39 IGKV1D-8	2.22e-08	183	160	9	dea119e2988e954475f557f0bbe12556a83e81a4
ToppCell	Mild-Lymphoid-B-\|Mild / Condition, Lineage, Cell class and cell subclass	IGKV1-39 IGKV1-27 IGKV1-9 IGKV1-8 PKHD1L1 IGLC7 IGLC2 IGLC3 IGKV1D-39	2.22e-08	183	160	9	b5740f05a4dcdbbf24f7bf7a3f57ac01a5e75f60
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGKV1-39 IGKV1-9 IGKV1-8 PKHD1L1 IGLV3-10 IGLC7 IGLC2 IGLC3 IGKV1D-39	2.33e-08	184	160	9	3f8a359e40bebe58545f708682e5e5d1b70cf5cb
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGKV1-39 IGKV1-9 IGKV1-8 PKHD1L1 IGLV3-10 IGLC7 IGLC2 IGLC3 IGKV1D-39	2.33e-08	184	160	9	64bede8db709fd32f40c03265b96f0b12155bb8a
ToppCell	BAL-Mild-Lymphocyte-B-B_cell\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGKV1-39 IGKV1-9 IGKV1-8 PKHD1L1 IGLV3-10 IGLC7 IGLC2 IGLC3 IGKV1D-39	2.44e-08	185	160	9	609080adb2cfb105bb7b8efb617553833299f371
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-8 IGKV3D-11 IGLC2 IGLC3 IGKV1D-43 IGKV1D-39 IGKV1D-8 IGKV3-11	2.44e-08	185	160	9	08bc817908076734d66f2805cb954141f2cc5a18
ToppCell	metastatic_Brain-B_lymphocytes\|metastatic_Brain / Location, Cell class and cell subclass	IGKV1-27 IGKV1-9 PKHD1L1 IGLC7 CD48 IGLC2 IGLC3 IGLC6 IGKV3-11	2.44e-08	185	160	9	153b82dc5ace03f84dc82d724d56bdc93aa020df
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-8 IGKV3D-11 IGLC2 IGLC3 IGKV1D-43 IGKV1D-39 IGKV1D-8 IGKV3-11	2.44e-08	185	160	9	1704a12153a9b107bf03ecccd1a036cf61334d7a
ToppCell	COVID-19-lung-Plasmablasts\|lung / Disease (COVID-19 only), tissue and cell type	IGKV1-39 IGKV1-9 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGKV1D-8 RPL7 IGKV3-11	2.56e-08	186	160	9	81caf67da9fed09c77b7ddcab9b0b8e4fab2de97
ToppCell	3'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-39 KLF6 TGFB1 IGLC7 CD48 IGLC2 IGLC3 IGLC6 IGKV3-11	2.81e-08	188	160	9	8e1220066008aef171692c6afffcf31833a3fae8
ToppCell	Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-27 IGKV1-9 PKHD1L1 IGLC7 IGLC2 IGLC3 IGLC6 IGKV1D-43 IGKV1D-39	3.22e-08	191	160	9	da4062a0f6d0af6d330acf11da216c64b0fa7c73
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-8 IGKV3D-11 IGLC2 IGLC3 IGKV1D-43 IGKV1D-39 IGKV1D-8 IGKV3-11	3.52e-08	193	160	9	282b47dae6043eabb1e13d41d91c07b5ec21cd65
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-27 IGKV1-8 IGKV3D-11 IGLC2 IGLC3 IGKV1D-39 IGKV1D-8 IGKV3-11	4.02e-08	196	160	9	c38e7f533c619afe008de0e99042f7180c2da918
ToppCell	COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast\|COVID_vent / Disease condition, Lineage, Cell class and subclass	IGKV1-39 IGKV1-9 IGLV3-10 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGKV1D-39 IGKV3-11	4.02e-08	196	160	9	026a06d8d2089806823e6f6453d3ede84ae93bc6
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	KCNMB2 DNAH3 NEDD4L SPEF2 AGR2 LMO7 CEP126 SDK1 DNAH11	4.02e-08	196	160	9	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-27 IGKV1-8 IGKV3D-11 IGLC2 IGLC3 IGKV1D-39 IGKV1D-8 IGKV3-11	4.02e-08	196	160	9	fec21383435779bf4c632decd3d29c6ca7baebfb
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 EFCAB6 SPEF2 DNAH2 EFCAB12 LMLN DLEC1 CEP126 DNAH11	4.20e-08	197	160	9	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	IGKV1-39 IGKV1-9 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGKV1D-39 IGKV1D-8 IGKV3-11	4.20e-08	197	160	9	1e63879633f20646e44873ae6b662f6faf4806fd
ToppCell	COVID_vent-Lymphocytic-Plasma_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	IGKV1-39 IGKV1-9 IGLV3-10 IGLC7 IGKV3D-11 IGLC2 IGLC3 IGKV1D-39 IGKV3-11	4.38e-08	198	160	9	e84c5f712e1dea548d0e2aba6625598f9671d3a0
ToppCell	Sepsis-URO-Lymphocyte-B-Plasmablast\|URO / Disease, condition lineage and cell class	IGKV1-39 IGKV1-9 IGKV1-8 MSH2 PKHD1L1 IGLC7 IGLC2 IGLC3 IGKV1D-39	4.58e-08	199	160	9	0df6cafb7f3b607cbe80b6f25b4fd62d421d01ee
ToppCell	tumor_Lymph_Node_/_Brain-B_lymphocytes-MALT_B_cells\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	IGKV1-27 IGKV1-9 IGKV1-8 PKHD1L1 IGLC7 IGLC2 IGLC3 IGKV1D-39	1.15e-07	159	160	8	204e5a675f4684c9570c24c8d34bbf632fd8164a
ToppCell	343B-Lymphocytic-Plasma_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-27 PKHD1L1 IGLC7 IGLC2 IGLC3 IGLC6 IGKV1D-39	1.46e-07	164	160	8	cf62d34ce9dd220fe61748466c84fd70d9ba697c
ToppCell	343B-Lymphocytic-Plasma_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-27 PKHD1L1 IGLC7 IGLC2 IGLC3 IGLC6 IGKV1D-39	1.46e-07	164	160	8	e00549bc8b3a5566f39031f39d7e698b0b107a7f
Computational	Genes upregulated in subsets of cells of a given type within various tumors	KLF6 IGLC7 IGLC1 IGLC2 IGLC3 IGLC6	5.32e-06	49	99	6	GAVISH_3CA_MALIGNANT_METAPROGRAM_36_IG
Drug	IC261	DNAH3 DNAH1 TGFB1 LMLN DNAH17 DYNC1H1 DYNC1I2 DNAH11	1.94e-07	96	146	8	CID000003674
Disease	juvenile polyposis syndrome (implicated_via_orthology)	HIVEP2 ACVR2A HIVEP3	3.48e-05	13	149	3	DOID:0050787 (implicated_via_orthology)
Disease	Proteinuria	MPV17 HLA-B SPP1 TGFB1	6.61e-05	43	149	4	C0033687
Disease	Glioma	HLA-B KLF6 SPP1 MSH2 ROS1	8.13e-05	87	149	5	C0017638
Disease	phenylketonuria (implicated_via_orthology)	DUOX2 DUOX1	1.51e-04	4	149	2	DOID:9281 (implicated_via_orthology)
Disease	Acute Erythroblastic Leukemia	EPOR CAD	1.51e-04	4	149	2	C0023440
Disease	Abnormality of head or neck	DHPS DYNC1I2	2.51e-04	5	149	2	C4021817
Disease	inflammatory biomarker measurement	VLDLR NPAS3 F5	3.01e-04	26	149	3	EFO_0004872
Disease	pancreatic ductal adenocarcinoma (is_marker_for)	AGR2 TGFB1 JAK1	3.38e-04	27	149	3	DOID:3498 (is_marker_for)
Disease	Iron deficiency anemia	DUOX2 F5	3.75e-04	6	149	2	HP_0001891
Disease	Hyalinosis, Segmental Glomerular	MPV17 SPP1 TGFB1	3.77e-04	28	149	3	C0086432
Disease	insomnia measurement	KCNMB2 NEDD4L OLFM4 NPAS3 ALMS1 SYT14 MED27 SDK1 DNAH11	4.38e-04	443	149	9	EFO_0007876
Disease	T-cell immunoglobulin and mucin domain 1 measurement	PTGFRN ITK	5.23e-04	7	149	2	EFO_0010812
Disease	morbid obesity (is_implicated_in)	MCHR1 BBS4	6.95e-04	8	149	2	DOID:11981 (is_implicated_in)
Disease	Focal glomerulosclerosis	MPV17 SPP1 TGFB1	7.97e-04	36	149	3	C0017668
Disease	interleukin 1 receptor-like 2 measurement	IGKV1-9 IGKV1-8	8.91e-04	9	149	2	EFO_0008169
Disease	primary bacterial infectious disease (implicated_via_orthology)	DUOX2 DUOX1	8.91e-04	9	149	2	DOID:0050338 (implicated_via_orthology)
Disease	blood molybdenum measurement	NPAS3 PTCH1 XKR4	9.35e-04	38	149	3	EFO_0007582
Disease	neutrophil percentage of granulocytes	HLA-B SPEF2 ACVR2A JAK1 HIVEP3 PRKDC	1.09e-03	228	149	6	EFO_0007994
Disease	Amyloidosis	APOC2 GSN	1.11e-03	10	149	2	C0002726
Disease	alpha wave measurement, electroencephalogram measurement	MSH2 DNAH1	1.11e-03	10	149	2	EFO_0004357, EFO_0006870
Disease	Prostatic Neoplasms	HNF1B KLF6 USP28 AGR2 NAGLU TGFB1 IVNS1ABP JAK1 SF3B1 PRKDC	1.19e-03	616	149	10	C0033578
Disease	Malignant neoplasm of prostate	HNF1B KLF6 USP28 AGR2 NAGLU TGFB1 IVNS1ABP JAK1 SF3B1 PRKDC	1.19e-03	616	149	10	C0376358
Disease	eosinophil percentage of granulocytes	HLA-B SPEF2 JAK1 HIVEP3 CCR3 PRKDC	1.25e-03	234	149	6	EFO_0007996
Disease	Cleft palate, isolated	NEDD4L PTCH1 TGFB1	1.25e-03	42	149	3	C1837218
Disease	autistic disorder (is_implicated_in)	NLGN3 NLGN4X KCNQ3	1.25e-03	42	149	3	DOID:12849 (is_implicated_in)
Disease	Basal cell carcinoma	XPC PTCH1	1.35e-03	11	149	2	C0007117
Disease	eosinophil count	DNAH3 HIVEP2 HLA-B SPEF2 ACVR2A AAGAB PTGFRN ITK JAK1 HIVEP3 TIGD2 UNK CCR3 IL1RL1 PRKDC MMP17 PLOD1	1.42e-03	1488	149	17	EFO_0004842
Disease	basophil count, eosinophil count	HLA-B SPEF2 JAK1 HIVEP3 UNK PRKDC	1.45e-03	241	149	6	EFO_0004842, EFO_0005090
Disease	chronic obstructive pulmonary disease (is_marker_for)	ABCC1 TGFB1 CCR3 IL1RL1	1.50e-03	97	149	4	DOID:3083 (is_marker_for)
Disease	basophil percentage of leukocytes	ABCC1 SLC36A1 SPEF2 ACVR2A CCR3 PRKDC	1.51e-03	243	149	6	EFO_0007992
Disease	Gastric Adenocarcinoma	ACVR2A ITK ROS1	1.53e-03	45	149	3	C0278701
Disease	alcohol consumption measurement	MMS22L CAD HLA-B USP28 DNAH2 NPAS3 XKR4 MBOAT2 ST6GAL2 ALMS1 SYT14 COMMD7 CSTF3 ASTN2 SDK1	1.60e-03	1242	149	15	EFO_0007878
Disease	familial hyperlipidemia (implicated_via_orthology)	APOC2 TGFB1	1.62e-03	12	149	2	DOID:1168 (implicated_via_orthology)
Disease	rhinitis (is_marker_for)	TGFB1 CCR3 IL1RL1	1.63e-03	46	149	3	DOID:4483 (is_marker_for)
Disease	Primary Ciliary Dyskinesia	SPEF2 DNAH1 DNAH11	1.74e-03	47	149	3	C4551720
Disease	end stage renal disease (biomarker_via_orthology)	EPOR TGFB1 LPIN1	1.74e-03	47	149	3	DOID:783 (biomarker_via_orthology)
Disease	Psychotic Disorders	HLA-B NPAS3 TGFB1 TENM4	1.74e-03	101	149	4	C0033975
Disease	gastroesophageal reflux disease	MMS22L HIVEP2 HLA-B SDK1	1.74e-03	101	149	4	EFO_0003948
Disease	obesity (is_marker_for)	APOC2 TGFB1 ACSL1 CCR3	1.74e-03	101	149	4	DOID:9970 (is_marker_for)
Disease	HIV Infections	HLA-B PTCH1 PSMD6 CCR3	1.87e-03	103	149	4	C0019693
Disease	HIV Coinfection	HLA-B PTCH1 PSMD6 CCR3	1.87e-03	103	149	4	C4505456
Disease	cholangiocarcinoma (biomarker_via_orthology)	EPOR TGFB1	1.90e-03	13	149	2	DOID:4947 (biomarker_via_orthology)
Disease	uveitis (is_implicated_in)	HLA-B TGFB1	1.90e-03	13	149	2	DOID:13141 (is_implicated_in)
Disease	hypothyroidism (implicated_via_orthology)	DUOX2 DUOX1	1.90e-03	13	149	2	DOID:1459 (implicated_via_orthology)
Disease	Autistic Disorder	VLDLR XPC IL1RAPL1 NLGN3 NLGN4X ASTN2	2.17e-03	261	149	6	C0004352
Disease	inflammatory biomarker measurement, YKL40 measurement	MSH2 PTCH1 ST6GAL2	2.20e-03	51	149	3	EFO_0004869, EFO_0004872
Disease	Malformations of Cortical Development	NDST1 DYNC1H1	2.21e-03	14	149	2	C1955869
Disease	congenital hypothyroidism (implicated_via_orthology)	DUOX2 DUOX1	2.21e-03	14	149	2	DOID:0050328 (implicated_via_orthology)
Disease	Cortical Dysplasia	NDST1 DYNC1H1	2.21e-03	14	149	2	C0431380
Disease	Nasal Cavity Polyp	HLA-B SPEF2 IL1RL1	2.73e-03	55	149	3	EFO_1000391
Disease	interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement	VLDLR F5	2.90e-03	16	149	2	EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293
Disease	revision of total joint arthroplasty, aseptic loosening	SLC6A6 MED27	2.90e-03	16	149	2	EFO_0010725, EFO_0020974
Disease	Cleft palate, cleft lip	PTCH1 CEMIP TENM4 SYT14 DLEC1 SDK1	3.01e-03	279	149	6	EFO_0003959, HP_0000175
Disease	Colorectal Carcinoma	ABCC1 DNAH3 CAD MSH2 F5 TGFB1 HIVEP3 LPIN1 NLGN4X LMO7	3.09e-03	702	149	10	C0009402
Disease	SLAM family member 7 measurement	IGLC7 CD48	3.28e-03	17	149	2	EFO_0008287
Disease	glycochenodeoxycholate measurement	CEMIP MED27	3.28e-03	17	149	2	EFO_0010490
Disease	Uremia	SPP1 TGFB1	3.28e-03	17	149	2	C0041948
Disease	Squamous cell carcinoma	XPC PTCH1 TGFB1 PRKDC	3.67e-03	124	149	4	C0007137
Disease	Allergic Reaction	HLA-B SPP1 TGFB1	4.02e-03	63	149	3	C1527304
Disease	fish consumption measurement	TENM4 COMMD7 SDK1	4.20e-03	64	149	3	EFO_0010139
Disease	arterial stiffness measurement	NPAS3 ACVR2A COMMD7	4.20e-03	64	149	3	EFO_0004517
Disease	Hypersensitivity	HLA-B SPP1 TGFB1	4.20e-03	64	149	3	C0020517
Disease	colorectal adenoma (is_marker_for)	PTCH1 F5	4.53e-03	20	149	2	DOID:0050860 (is_marker_for)
Disease	allergic rhinitis	HLA-B SPEF2 DLEC1 IL1RL1	4.70e-03	133	149	4	EFO_0005854
Disease	eosinophil percentage of leukocytes	HIVEP2 HLA-B SPEF2 AAGAB JAK1 HIVEP3 UNK CCR3 IL1RL1 PRKDC	4.73e-03	746	149	10	EFO_0007991
Disease	osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty	PTCH1 TGFB1	4.99e-03	21	149	2	EFO_0004616, EFO_0010726, EFO_1000786

Protein segments in the cluster

Peptide	Gene	Start	Entry
NTEWIDKVYLPTNCY	ACCSL	441	Q4AC99
QLIWTQTYEEALYKS	AGR2	51	O95994
IRWKINNLIASESYY	CATSPERG	1101	Q6ZRH7
ANYLAPFDWKILYNL	BBS4	296	Q96RK4
NDSYALVIDWAPKGY	ERVK11-1	121	P61568
SYWESAKTAAQNLYE	APOC2	46	P02655
ISSQSYYQKAIWELQ	BTNL8	116	Q6UX41
YYQKAIWELQVSALG	BTNL8	121	Q6UX41
QPYEWLSYKQVAELS	ACSL1	116	P33121
YSSNKEEWISLAYRP	ALG9	551	Q9H6U8
KQSWQNEYEVYSLPG	ACVR2A	226	P27037
WKPYAVYLLNLALAD	GPR31	46	O00270
SSSWDTYYQPRALEK	ABHD16A	41	O95870
IFYQQEWPDSYATEK	ALMS1	1011	Q8TCU4
YNYLEANSKVPWEDL	DNAH11	4121	Q96DT5
ESLEKPLNWLLFNYY	ABHD3	256	Q8WU67
YQLKVDLWQPSSISY	CPA6	61	Q8N4T0
QLTRKSLQDYYWQIS	CC2D2B	356	Q6DHV5
SEYPGSYLTKNDNWL	CEMIP	966	Q8WUJ3
YTVLPSWVKNLAQYG	GKN3P	116	P0CG01
YYSDWKVFSPNLALL	EFCAB12	441	Q6NXP0
WLNPAKLSLYYQINA	ASTN2	491	O75129
KLSLYYQINATSPWV	ASTN2	496	O75129
KQLAGLVANYYTPRW	NAGLU	661	P54802
SWSPKDKYNYIGLSQ	RANBP10	56	Q6VN20
QLYNKYPDAVATWLN	SPP1	31	P10451
KAWNAYPYCRTVITN	PITPNA	86	Q00169
PYEKVNLSWYNGTVN	SPINK14	41	Q6IE38
YDENTKLWYAPNRTI	JAK1	81	P23458
SQSVSSYLAWYQQKP	IGKV3D-11	46	A0A0A0MRZ8
TYQNIAVYEWLPSFL	DUOX1	286	Q9NRD9
ISSYLNWYQQKPGKA	IGKV1D-39	51	P04432
WKLSQYPCLQVYVNL	KCNMB2	106	Q9Y691
LAYSNLVYDWVKAAV	HHATL	291	Q9HCP6
PKYYFAWTLADAINN	MBOAT2	286	Q6ZWT7
AYWYQQKSGQAPVLV	IGLV3-10	51	A0A075B6K4
YNLESNEWSPYTKIF	IVNS1ABP	626	Q9Y6Y0
AIVTILWEYYSKNLN	MMS22L	421	Q6ZRQ5
YTIKAYAWNANRIPG	FNDC7	176	Q5VTL7
ISSYLAWYQQKPAKA	IGKV1D-43	51	A0A0B4J1Z2
NKEDPTYTVWYLGNA	FAM43B	66	Q6ZT52
AELIQAAWRYYATNP	KCNQ3	376	O43525
PFNYSLGLYQWSDKV	LMLN	306	Q96KR4
ISSYLAWYQQKPGKA	IGKV1D-8	51	A0A087WSZ0
DWSSQYPELLVASYN	DYNC1I2	286	Q13409
ATYQNIAVYEWLPSF	DUOX2	291	Q9NRD8
FYRWYQLEKTNPGAT	HMBOX1	221	Q6NT76
AEQLYKLNAPIWYLV	MAP3K6	461	O95382
DAYLSYTKVDPDQWN	IL1RAPL1	406	Q9NZN1
PDIWYEAAQYLEQSS	CSTF3	291	Q12996
LSLWPAYNLTEQYLQ	CES5A	506	Q6NT32
NSLLNPLIYAYWQKE	GPR119	271	Q8TDV5
LIYKTYTLQDGPWSQ	ABCC11	31	Q96J66
TILINPADRAYSWYQ	NDST1	701	P52848
ITLYWLGRKAQSNPY	LMO7	171	Q8WWI1
SKYYNWTTAAPLLLA	LPIN1	511	Q14693
TPLYSQLLQAYKWSN	MED27	101	Q6P2C8
YKPLNDSVRAQYSNW	POGK	511	Q9P215
AWGYPNLKSVNELIY	RPL7	141	P18124
VEPNSLWSLIQYAYT	KLHL5	266	Q96PQ7
PEYWDRNTQIYKAQA	HLA-B	81	P01889
KAWNAYPYCRTIVTN	PITPNB	86	P48739
WNVPYISNIYLIKGS	PLOD1	446	Q02809
ASVRIANLLPAWYYN	PTPRO	591	Q16827
EAYNASAVKLIWYLP	PTPRQ	206	Q9UMZ3
SALSSWAVNYQPVKY	NLGN3	316	Q9NZ94
WAVNYQPVKYTSLLA	NLGN3	321	Q9NZ94
SWAVNYQPAKYTRIL	NLGN4Y	286	Q8NFZ3
WLVYANSAANPIIYN	HCRTR2	351	O43614
LYNNTVPELWSAKAY	DNAH1	4066	Q9P2D7
VDWYYSQTNKSIPTQ	IL1RL1	46	Q01638
YAASSYLSLTPEQWK	IGLC1	66	P0CG04
FWTPYNVAILLSSYQ	CCR3	251	P51677
KSCYWPALQNVYTNV	DNAH17	261	Q9UFH2
KVPYEQLWSTAYEFS	DNAH3	866	Q8TD57
SLPAWYKSALFNELY	GBA2	471	Q9HCG7
LTPYINWKYFLQNFS	EFCAB6	1121	Q5THR3
YDWNARVTAKVPSSY	FCGBP	981	Q9Y6R7
PWQVSLQYEKSGSFY	CELA3A	41	P09093
LSKSNVLPSWEYFNS	CEP126	331	Q9P2H0
YLALLQAYKGWQLST	DHX57	1121	Q6P158
GKEINNPESVYYWAQ	DHPS	211	P49366
YAASSYLSLTPEQWK	IGLC2	66	P0DOY2
YAASSYLSLTPEQWK	IGLC3	66	P0DOY3
YAASSYLSLTPEQWK	IGLC6	66	P0CF74
ATYFSEKWKQNAPTL	COMMD7	106	Q86VX2
YSLPFYEIDWNQKLA	C1orf100	101	Q5SVJ3
PWQVSLQYEKSGSFY	CELA3B	41	P08861
VLYSTPACYLWELNK	MAN2B1	351	O00754
VCWAPYYVLQLTQLS	MCHR1	336	Q99705
ILYSNWLSKDYIPVD	DYNC1H1	2871	Q14204
NYSFSYQLEDEPWKL	EPOR	76	P19235
SQGISSYLAWYQQKP	IGKV1-8	46	A0A0C4DH67
ISSYLAWYQQKPGKA	IGKV1-9	51	A0A0C4DH69
ISNYLAWYQQKPGKV	IGKV1-27	51	A0A075B6S5
ISSYLNWYQQKPGKA	IGKV1-39	51	P01597
SQSVSSYLAWYQQKP	IGKV3-11	46	P04433
NDAFVLKTPSAAYLW	GSN	591	P06396
YAASSYLSLTPEQWK	IGLC7	66	A0M8Q6
SESLPENYKQLTWFY	CD48	46	P09326
NGAWSYLPVYAEVQK	DLEC1	951	Q9Y238
TPWDALKYLIAGINY	DNAH2	4031	Q9P225
LYYIVELSENNSPWK	SDK1	701	Q7Z5N4
LNYVQILWDYKAPSQ	SLC19A3	296	Q9BZV2
ILWDYKAPSQDSSIY	SLC19A3	301	Q9BZV2
DWYLAYKASPGNLSQ	MSH2	116	P43246
SWAVNYQPAKYTRIL	NLGN4X	286	Q8N0W4
LALAADWLQAPYLYK	MFSD5	51	Q6N075
APYYEALCKSLDWQI	PSMD6	51	Q15008
LVEKSPNNLETYEWY	ITK	226	Q08881
PNNLETYEWYNKSIS	ITK	231	Q08881
QKAYYPSIVANRWLA	ABCC1	1186	P33527
FKWGPASQQILYQAY	HNF1B	236	P35680
VTWLEPDYQVYLNAS	PTGFRN	401	Q9P2B2
IGAAALWALIYNYQK	RTTN	2161	Q86VV8
LWALIYNYQKAKTAL	RTTN	2166	Q86VV8
GQIYQSWLDKSTPYT	RER1	26	O15258
QLSYAGDPQYQKLWK	DROSHA	781	Q9NRR4
FLVPYWELIENSYIN	SPEF2	1026	Q9C093
YAWETRQKYSPLSAE	SYT14	121	Q8NB59
TYYLFQSFQKELPWA	SLC6A6	146	P31641
TPSIYFWYQQALKAS	SLC6A16	241	Q9GZN6
RAWAYYSAVNPEKDI	F5	1726	P12259
YYALKVWSDIAPLNF	MMP17	161	Q9ULZ9
IYLTAWVSNDPVAYA	PTCH1	921	Q13635
SANLNLWYKKPDYNL	ST6GAL2	376	Q96JF0
LITNYYLWPAVQLAN	MPV17	131	P39210
IIWVNYLLSNPEYKD	NPAS3	426	Q8IXF0
WTGSAPILQQYYNTK	TGM4	246	P49221
YLLAAQLGKNYISAW	WDR18	51	Q9BV38
QVLNTWYTKQYKPSA	OLFM4	416	Q6UX06
FYVPEGSWNYKLNTI	SPATA1	41	Q5VX52
PWTIDNKYYSADINL	AAGAB	46	Q6PD74
QLYAAQSTKSPWNFL	CLPTM1	316	O96005
SAISWILYCLAKYPE	CYP4Z1	321	Q86W10
SLAYPTAVNWNAYAT	VNN2	311	O95498
PVTYYSQKGAWIEQS	TIGD2	246	Q4W5G0
AYASYIPGSIIWAKQ	ZCWPW1	311	Q9H0M4
PKFISNQTIYYSWEG	NCAM2	401	O15394
LPNCWLYQSVKLLYS	SLC36A1	326	Q7Z2H8
KNSSYFADWLPNNVK	TUBB8	336	Q3ZCM7
VVYPSNQTLKDYLSW	THG1L	161	Q9NWX6
WKIYNSIYIGSQDAL	SF3B1	1266	O75533
CPYIWSLDTQYSKVL	TGFB1	326	P01137
TTNVSWCYLNYIKPN	HIVEP3	1601	Q5T1R4
YSLREKLPANQYTWS	TPP2	396	P29144
LWEQELYSQLVYSTP	WAS	96	P42768
LYVAAKNGYPWVLEN	TTC41P	141	Q6P2S7
LSALWYLYKAPQIAD	XKR4	471	Q5GH76
SINDKPLWRYSYDLN	TENM4	2206	Q6N022
YWIITAKDSTQIYQA	ROS1	1396	P08922
YKAWSSIVYQLIPNV	RRAGB	231	Q5VZM2
RDSTCKYLPEWQSYQ	PKHD1L1	3746	Q86WI1
YNQPRQSWLKYNDIS	USP28	606	Q96RU2
NKWEAYLGLLQAEYT	POLR2L	16	P62875
VAAEWPAQTNYLYLT	CAD	906	P27708
DLNKIWSEPFYQETY	PRKDC	3026	P78527
PRDVDTYYLSNLVKW	XPC	246	Q01831
WILAYSQDQKLYSSA	SORCS1	286	Q8WY21
TVSWCFLNYTKPNYV	HIVEP2	1646	P31629
WQETAYVLGNYKTEP	UNK	206	Q9C0B0
VIIAKYLAQWYSETN	NAE1	216	Q13564
YLAQWYSETNGRIPK	NAE1	221	Q13564
SNSPNYEEITKWYLG	TFIP11	671	Q9UBB9
NVYNPAAIAVDWVYK	VLDLR	511	P98155
AASVYQPAQLLNWVY	ZCCHC24	11	Q8N2G6
YFSALPSLEEYWQQT	KLF6	21	Q99612
NLASVEYYNPTTDKW	KLHL2	556	O95198
YYNSLKWILENDPTE	NEDD4L	756	Q96PU5